Metabolic
Retatrutide
10 mg
Research Use Only
Triple agonist reference peptide for metabolic pathway research.
Price on Request
In stockInternal Batch
GA-24-101
Category
Metabolic
Certificate of Analysis
Third-party testing in progress
The Certificate of Analysis will be published upon completion.
What Is This Compound?
Retatrutide is an investigational peptide designed to activate the GIP receptor, GLP-1 receptor, and glucagon receptor.
Scientific Overview
Researchers are evaluating how combined activation of these pathways affects metabolism, energy regulation, and receptor signalling.
Research Status
Investigational triple-receptor agonist. Do not describe it as an approved medicine or as having established general clinical outcomes.
Primary Research Areas
- GIP receptor signalling
- GLP-1 receptor signalling
- Glucagon receptor signalling
- Metabolic pathway research
Biological Pathway or Mechanism
Triple-agonist research candidate at GIPR, GLP-1R and GCGR, studied within incretin and metabolic receptor-signalling pathways.
Scientific descriptions are provided in English to preserve accurate terminology.
Product Specifications
COA & Batch Documentation
Lot Number: GA-24-101
The Certificate of Analysis will be published upon completion.
This Certificate of Analysis applies only to the tested sample and the lot identified in the original laboratory document. It must not be interpreted as applying to another product, strength, lot, or batch.
Potential Benefits
The information below is provided for educational and scientific discussion purposes only. It summarizes research areas that have been explored in laboratory, preclinical, or published scientific research. It is not medical advice and must not be interpreted as evidence of safety, effectiveness, or suitability for human use.
- Studied in laboratory research involving GIP receptor signalling
- Investigated in preclinical research related to GLP-1 receptor pathway models
- Explored in published research concerning glucagon receptor biology in vitro
- Examined in laboratory models of incretin and metabolic-pathway mechanisms
FDA Disclaimer
† These statements have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Research Disclaimer — Research Use Only
This information is provided for general scientific and educational purposes. The product is not intended for human consumption, diagnosis, treatment, prescribing, administration, or dosing. References to approved medicines do not mean that this research product is equivalent to an approved pharmaceutical product.
